thromboxanes has been researched along with Liver Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bland, KI; Chaudry, IH; Nagino, M; Nimura, Y; Yokoyama, Y | 1 |
| Lucia, JF | 1 |
| Kronborg, IJ; Radvan, G; Zipser, RD | 1 |
| Duke, R; Kronborg, IJ; Little, TE; Radvan, GH; Zipser, RD | 1 |
| Epstein, M | 1 |
3 review(s) available for thromboxanes and Liver Diseases
| Article | Year |
|---|---|
Role of thromboxane in producing hepatic injury during hepatic stress.
Topics: Animals; Biomarkers; Disease Progression; Female; Humans; Kupffer Cells; Liver; Liver Circulation; Liver Diseases; Male; Prognosis; Receptors, Thromboxane; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Thromboxanes | 2005 |
[Acquired changes in platelet function].
Topics: Blood Coagulation; Blood Platelet Disorders; Blood Platelets; Blood Transfusion; Cyclic AMP; Humans; Hypoglycemia; Liver Diseases; Lymphoproliferative Disorders; Pharmacology; Platelet Aggregation; Platelet Transfusion; Prostaglandins; Purpura, Thrombocytopenic; Thromboxanes; Uremia | 1984 |
Renal prostaglandins and the control of renal function in liver disease.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney; Kidney Diseases; Liver Cirrhosis; Liver Diseases; Prostaglandins; Sodium; Thromboxanes; Water-Electrolyte Balance | 1986 |
2 other study(ies) available for thromboxanes and Liver Diseases
| Article | Year |
|---|---|
Urinary excretion of prostaglandins and thromboxanes in the hepatorenal syndrome.
Topics: Dinoprostone; Humans; Kidney Diseases; Kidney Failure, Chronic; Liver Diseases; Prostaglandins E; Syndrome; Thromboxane B2; Thromboxanes | 1983 |
Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: evidence for increased vasoconstrictor and decreased vasodilator factors.
Topics: Acute Disease; Acute Kidney Injury; Adolescent; Adult; Biological Assay; Chronic Disease; Dinoprostone; Female; Humans; Kidney Diseases; Kidney Failure, Chronic; Liver Diseases; Male; Mass Spectrometry; Middle Aged; Prostaglandins E; Radioimmunoassay; Syndrome; Thromboxane B2; Thromboxanes | 1983 |